Semaglutide and tirzepatide recommended as first-line treatment of obesity and most of its complications in new guidance from European Association for the Study of Obesity (EASO) Semaglutide and tirzepatide recommended as first-line treatment of obesity and most of its complications in new guidance from European Association for the Study of Obesity (EASO) Research
Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity Policy, Research
Person First Language Guide: Addressing Weight Bias Person First Language Guide: Addressing Weight Bias Education, Resources
Partnership Overweight Netherlands (PON) publishes new guidelines on overweight and obesity in adults Partnership Overweight Netherlands (PON) publishes new guidelines on overweight and obesity in adults Guidelines, Member News, Resources
New Obesity Treatment Guidelines in Chile use a chronic disease framework, with focus on patient-centered health outcomes New Obesity Treatment Guidelines in Chile use a chronic disease framework, with focus on patient-centered health outcomes Guidelines, Resources
New obesity treatment and care guidelines launched in Ireland New obesity treatment and care guidelines launched in Ireland Guidelines, Resources
